Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | THPO | P40225 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.56 |
| ▸ | APP | P05067 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
| ▸ | MMP12 | P39900 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | HTR2A | P28223 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL80946 | 0.86 | CYP1A2 (0.54) | CYP1A2CYP3A4CYP2C9CYP2C19THPO | |
| SCHEMBL6446069 | 0.86 | MMP2 (0.55) | CYP1A2CYP3A4CYP2C9CYP2C19THPO | |
| SCHEMBL10753670 | 0.85 | LMNA (0.50) | CYP1A2CYP3A4CYP2C9CYP2C19THPO | |
| SCHEMBL7377156 | 0.83 | APP (0.48) | CYP1A2CYP3A4CYP2C9CYP2C19THPO | |
| SCHEMBL11216527 | 0.83 | FFAR1 (0.49) | CYP1A2CYP3A4CYP2C9CYP2C19THPO | |
| SCHEMBL5633251 | 0.82 | ALDH1A1 (0.47) | CYP1A2CYP3A4CYP2C9CYP2C19THPO | |
| SCHEMBL9487985 | 0.81 | LMNA (0.46) | CYP1A2CYP3A4CYP2C9CYP2C19THPO | |
| SCHEMBL11485198 | 0.81 | ALDH1A1 (0.44) | CYP1A2CYP3A4CYP2C9CYP2C19THPO | |
| SCHEMBL5020586 | 0.81 | ALDH1A1 (0.50) | CYP1A2CYP3A4CYP2C9CYP2C19THPO | |
| SCHEMBL6298845 | 0.81 | LTA4H (0.52) | LMNAKDM4EMMP2MMP12FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 693 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119684966-B | Hot-moisture dual-cured organic silicon sealant and preparation method thereof | 广州白云科技股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| US-20260078296-A1 | SUSTAINED-RELEASE SCALE INHIBITORS | Materials Engineering and Technical Support Services (US) | 2026-03-19 | — | — | US | claimed |
| CN-120004883-A | Acidizing corrosion inhibitor, acidizing working solution, preparation method and application of acidizing working solution | 延长油田股份有限公司杏子川采油厂 | 2025-05-16 | — | — | CN | claimed |
| CN-119684966-A | Hot-moisture dual-cured organic silicon sealant and preparation method thereof | 广州白云科技股份有限公司 | 2025-03-25 | — | — | CN | claimed |
| CN-118108718-A | Benzimidazolo [1,2-b ] isoquinoline compounds, and preparation and application thereof | 中国科学院大连化学物理研究所 | 2024-05-31 | — | — | CN | claimed |
| CN-117466790-B | Preparation method of alpha-sulfinylated carbonyl compound | 西北师范大学 | 2024-05-28 | — | — | CN | claimed |
| WO-2024059615-A2 | SUSTAINED-RELEASE SCALE INHIBITORS | MATERIALS ENGINEERING AND TECHNICAL SUPPORT SERVICES CORPORATION (US) | 2024-03-21 | — | — | WO | claimed |
| CN-117466790-A | Preparation method of alpha-sulfinylated carbonyl compound | 西北师范大学 | 2024-01-30 | — | — | CN | claimed |
| CN-117327073-A | Preparation method of chiral tetrahydroisoindolo [2,1-a ] quinoxaline compound | 中国科学院大连化学物理研究所 | 2024-01-02 | — | — | CN | claimed |
| CN-115650914-A | Preparation method of indenoquinoline derivative | 广东工业大学 | 2023-01-31 | — | — | CN | claimed |
| EP-0871619-B1 | PHENYL THIAZOLE DERIVATIVES WITH ANTI HERPES VIRUS PROPERTIES | BOEHRINGER INGELHEIM PHARMA (US) | 2002-11-06 | — | — | EP | claimed |
| EP-1157003-A1 | ACYLATED AMINOACETONITRILES AS CYSTEINE PROTEASE INHIBITORS | AstraZeneca AB (SE) | 2001-11-28 | — | — | EP | claimed |
| WO-2000048992-A1 | ACYLATED AMINOACETONITRILES AS CYSTEINE PROTEASE INHIBITORS | ASTRAZENECA AB (SE) | 2000-08-24 | — | — | WO | claimed |
| US-5696268-A | REACTING N-ACYLAMINO ACID DERIVATIVE WITH OPTICALLY ACTIVE ENAMINE DERIVATIVE, REACTING PRODUCT WITH AMMONIA OR AMMONIUM SALT | FUJIREBIO INC. (JP) | 1997-12-09 | — | — | US | claimed |
| EP-0589446-B1 | N-(Hydroxyethyl)butanediamide derivatives as renin inhibitors | BOEHRINGER INGELHEIM CA LTD (CA) | 1997-09-03 | — | — | EP | claimed |
| US-5644059-A | REACTION OF KETONE WITH ACRYLAMIDE AND AMMONIA OR AMMONIUM SALT | FUJIREBIO INC. (JP) | 1997-07-01 | — | — | US | claimed |
| EP-0404030-B1 | Method for coating substrates with UV curable epoxysilicone compositions | GEN ELECTRIC (US) | 1994-02-09 | — | — | EP | claimed |
| EP-0488345-A1 | 1,4-Dihydropyridine derivatives and methods of producing the same | FUJIREBIO INC. (JP) | 1992-06-03 | — | — | EP | claimed |
| US-4428870-A | Perfume composition containing phenylethynyl carbinols | FRITZSCHE DODGE & OLCOTT INC. (US) | 1984-01-31 | — | — | US | claimed |
| US-4081468-A | HERBICIDES | STAUFFER CHEMICAL COMPANY (US) | 1978-03-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078296-A1 | SUSTAINED-RELEASE SCALE INHIBITORS | CEL, TST, CD44 | CYP1A2 2037/4885CYP3A4 1470/4885CYP2C9 1523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.